Pancreatic Cancer Research

ResearcherNorthern Jiangsu People's HospitalNo recent work listed

Dong Tang

Matched on ORCID iD 0000-0002-2057-2968; OpenAlex author ID A5102881250. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 8

  1. Identification of key pathways and gene changes in primary pancreatic stellate cells after cross-talk with pancreatic cancer cells (BXPC-3) using bioinformatic… Co-author DOI 10.4149/neo_2018_180925n714↗
  2. PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway. Co-author DOI 10.18632/oncotarget.21212↗
  3. Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer. Co-author DOI 10.1007/s13277-015-3233-5↗
  4. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0090476↗
  5. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.27715↗
  6. MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2. Co-author DOI 10.1016/j.canlet.2012.11.005↗
  7. High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreat… Co-author DOI 10.1002/ijc.26290↗
  8. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an i… Co-author DOI 10.1097/mpa.0b013e318217945e↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongxu Yuan · 5 shared papers, 2012–2017 · strength 0.20
  2. Daorong Wang · 4 shared papers, 2013–2017 · strength 0.17
  3. Yi Miao · 5 shared papers, 2011–2015 · strength 0.17
  4. Kuirong Jiang · 5 shared papers, 2011–2015 · strength 0.17
  5. Yong An · 4 shared papers, 2011–2013 · strength 0.11
  6. Xiaofeng Xue · 4 shared papers, 2011–2013 · strength 0.11
  7. Jishu Wei · 4 shared papers, 2011–2013 · strength 0.11
  8. Jun Gao · 2 shared papers, 2014–2015 · strength 0.08
  9. Zipeng Lu · 3 shared papers, 2011–2013 · strength 0.08
  10. Zhengyu Jin · 1 shared paper, 2019 · strength 0.08
  11. D. Wang · 1 shared paper, 2019 · strength 0.08
  12. Min Tu · 2 shared papers, 2013 · strength 0.06
  13. Ying Tian · 1 shared paper, 2017 · strength 0.06
  14. Qiang Li · 2 shared papers, 2011–2013 · strength 0.05
  15. Wentao Gao · 2 shared papers, 2011–2013 · strength 0.05
  16. Junli Wu · 2 shared papers, 2011–2013 · strength 0.05
  17. Jie J. Yao · 2 shared papers, 2011–2013 · strength 0.05
  18. Chuanqi Xu · 1 shared paper, 2015 · strength 0.04
  19. Jian‐Min Chen · 1 shared paper, 2013 · strength 0.03
  20. Yi Miao · 1 shared paper, 2013 · strength 0.03
  21. Baobao Cai · 1 shared paper, 2013 · strength 0.03
  22. Kuirong Jiang · 1 shared paper, 2013 · strength 0.03
  23. Yi Zhu · 1 shared paper, 2012 · strength 0.03
  24. Zekuan Xu · 1 shared paper, 2011 · strength 0.02
  25. Zhuyin Qian · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.